APA (7th ed.) Citation

P, L., A, G., S, R., P, C., J, v. T., O, A., . . . M, H. (2024). Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies. Blood, 143(25), 2588. https://doi.org/10.1182/blood.2023022564

Chicago Style (17th ed.) Citation

P, Langerbeins, et al. "Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the Era of Targeted Therapies." Blood 143, no. 25 (2024): 2588. https://doi.org/10.1182/blood.2023022564.

MLA (9th ed.) Citation

P, Langerbeins, et al. "Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the Era of Targeted Therapies." Blood, vol. 143, no. 25, 2024, p. 2588, https://doi.org/10.1182/blood.2023022564.